Molbio Diagnostics, a diagnostics player, announced the appointment of two independent directors to its board, Balram Bhargava and Arun Kumar Jha. These appointments come as the company continues to strengthen its leadership, says a company statement.
"These appointments reflect Molbio Diagnostics’ commitment to bringing on board leaders who are at the forefront of healthcare innovation and public health policy," said Sriram Natarajan, director and CEO of Molbio Diagnostics.
``Dr Jha and Dr Bhargava’s impressive backgrounds and shared dedication to improving healthcare access aligns perfectly with our vision of transforming global health landscapes," he added.
A business journalist with around two decades of experience track...
Read MoreA business journalist with around two decades of experience tracking key consumer-focussed sectors like consumer durables, retail, consumer goods, aviation, automobiles and advertising, as well as economic ministries of the Union government. Now, writes primarily on pharmaceuticals and healthcare, and on issues of consumer interest. Besides also looks at trends that are shaping consumer behaviour and the broad consumer landscape. \nYou can follow Rupali on Twitter@Rupalijee.
Read Less
Start a Conversation
Post comment